SCHEMBL9891366

SCHEMBL9891366

CC1(C)OB(c2ccc3c(c2)[nH]c2ccccc23)OC1(C)C

nearest known ligand 0.49

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 10/20 0.49
LPL P06858 3/20 0.47
LIPG Q9Y5X9 3/20 0.47
AHR P35869 1/20 0.47
ALDH1A1 P00352 1/20 0.44
GPR3 P46089 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PRMT5 O14744 1/20 0.40
WDR77 Q9BQA1 1/20 0.40
PGR P06401 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19896283 0.92 LPL (0.46) LPLLIPGPRMT5WDR77
SCHEMBL1542754 0.91 LPL (0.47) KIF11LPLLIPGAHRALDH1A1
SCHEMBL29392223 0.91 LPL (0.47) KIF11LPLLIPGAHRALDH1A1
SCHEMBL29551267 0.91 LPL (0.47) KIF11LPLLIPGAHRALDH1A1
SCHEMBL16305024 0.86 LIPG (0.48) KIF11LPLLIPGAHRALDH1A1
SCHEMBL28356399 0.86 LPL (0.51) KIF11LPLLIPGAHRALDH1A1
SCHEMBL28356643 0.86 LPL (0.51) KIF11LPLLIPGAHRALDH1A1
SCHEMBL30211905 0.86 LIPG (0.48) KIF11LPLLIPGAHRALDH1A1
Biphenyl SCHEMBL28999907 0.85 LIPG (0.58) KIF11LPLLIPGAHRALDH1A1
SCHEMBL20227726 0.85 PARP1 (0.47) LPLLIPGALDH1A1GPR3HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035398-A1 TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES UNIV ARIZONA STATE (US) 2026-02-05 US disclosed
EP-4051667-B1 HETEROCYCLIC CARBOXYLATE COMPOUNDS AS GLYCOLATE OXIDASE INHIBITORS LILAC THERAPEUTICS INC (US) 2026-01-28 EP disclosed
US-20250311611-A1 POLYMERIC COMPOUND, AND ELECTROLUMINESCENCE DEVICE MATERIAL AND ELECTROLUMINESCENCE DEVICE INCLUDING THE POLYMERIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2025-10-02 US disclosed
US-12384760-B2 Substituted carbazole compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2025-08-12 US disclosed
EP-4592284-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2025-07-30 EP disclosed
US-12312366-B2 Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2025-05-27 US disclosed
CN-119907793-A Compound for organic optoelectronic device, composition for organic optoelectronic device, and display device 三星SDI株式会社 2025-04-29 CN disclosed
US-20250133897-A1 LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2025-04-24 US disclosed
EP-4529393-A1 LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND Samsung Display Co., Ltd. (KR) 2025-03-26 EP disclosed
US-20250064787-A1 Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors LILAC THERAPEUTICS INC (US) 2025-02-27 US disclosed
EP-2790239-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT Idemitsu Kosan Co., Ltd (JP) 2014-10-15 EP disclosed
US-20140088096-A9 PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-03-27 US disclosed
US-20130217682-A1 PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-08-22 US disclosed
WO-2013123169-A1 PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-08-22 WO disclosed
US-20120245124-A1 TRPV3 Modulators ABBOTT LABORATORIES (US) 2012-09-27 US disclosed
WO-2012129491-A1 TRPV3 MODULATORS ABBOTT LABORATORIES (US) 2012-09-27 WO disclosed
US-20120138911-A1 BISCARBAZOLE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. 2012-06-07 US disclosed
US-20120080670-A1 COMPOUND CONTAINING A 5-MEMBERED HETEROCYCLE AND ORGANIC LIGHT-EMITTING DIODE USING SAME, AND TERMINAL FOR SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2012-04-05 US disclosed
US-20120080670-A1 COMPOUND CONTAINING A 5-MEMBERED HETEROCYCLE AND ORGANIC LIGHT-EMITTING DIODE USING SAME, AND TERMINAL FOR SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2012-04-05 US disclosed
US-20110278555-A1 BISCARBAZOLE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. 2011-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120138911-A1 BISCARBAZOLE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME UQCRB, OXA1L, HBS1L KIF11 3915/4885LPL 4857/4885LIPG 4816/4885
US-20260035398-A1 TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES LBR, SCO2, RAD54L KIF11 4839/4885LPL 4467/4885LIPG 4627/4885
US-20120245124-A1 TRPV3 Modulators TRPV3, TRPV2, TRPV1 KIF11 4349/4885LPL 3028/4885LIPG 3200/4885
US-20130217682-A1 PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME UBA1, UBXN1, UBE2E1 KIF11 2999/4885LPL 3748/4885LIPG 4100/4885
US-20110278555-A1 BISCARBAZOLE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME UQCRB, OXA1L, HBS1L KIF11 3915/4885LPL 4857/4885LIPG 4816/4885
US-12312366-B2 Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues PAICS, DNTT, PNPO KIF11 1936/4885LPL 3144/4885LIPG 3803/4885
US-20140088096-A9 PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME UBA1, UBXN1, UBE2E1 KIF11 2999/4885LPL 3748/4885LIPG 4100/4885
US-20120080670-A1 COMPOUND CONTAINING A 5-MEMBERED HETEROCYCLE AND ORGANIC LIGHT-EMITTING DIODE USING SAME, AND TERMINAL FOR SAME NOTUM, OR10J3, PER2 KIF11 3123/4885LPL 1751/4885LIPG 2148/4885
US-12384760-B2 Substituted carbazole compounds TLR7, TLR3, TLR1 KIF11 4633/4885LPL 3064/4885LIPG 2581/4885
US-20250064787-A1 Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors GLS, DUOX1, HAO1 KIF11 3880/4885LPL 1856/4885LIPG 1139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.